PRENATAL DIAGNOSIS TRIALS--FETAL CELLS/MATERNAL BLOOD
产前诊断试验——胎儿细胞/母血
基本信息
- 批准号:6045787
- 负责人:
- 金额:$ 21.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-03-15 至 1999-10-31
- 项目状态:已结题
- 来源:
- 关键词:chromosome aberrations clinical trials diagnosis design /evaluation diagnosis quality /standard female flow cytometry fluorescent dye /probe genetic disorder diagnosis human fetus tissue human pregnant subject in situ hybridization noninvasive diagnosis nucleic acid probes pregnancy circulation prenatal diagnosis psychological tests
项目摘要
This project represents phase II of a project whose main objective is to
develop a non-invasive, safe, relatively inexpensive and accurate
technique for the prenatal diagnosis of genetic disorders that can be
performed during the first trimester. Phase II will test, expand and
refine the methodology developed in phase I. The study will include a
systematic evaluation of the variables involved in separating and
enriching fetal cells from maternal blood through flow cytometry or other
methods, including magnetic-activated cell sorting (MACS), followed by
in situ hybridization with chromosome-specific DNA probes. The results
of these peripheral blood studies will be compared to those that will be
obtained from amniocentesis or chorionic villus sampling (CVS) on the
same women.
Another objective of the project is to determine whether or not there are
any non-biological effects on the women undergoing prenatal diagnostic
testing. Even if the biologic risks associated with reproductive genetic
technologies are reduced, the possibility exists that other potential
risks (or benefits) are associated with the procedures. Some of these
factors may be: expanded or diminished maternal anxiety, increased
adjustment or maladaptation to the pregnancy, increased feelings Of
coercion to undertake prenatal testing when there are negligible biologic
risks associated with the procedure, and increased or decreased comfort
with reproductive decision-making.
本项目是一个项目的第二阶段,其主要目标是
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DIANA W. BIANCHI其他文献
DIANA W. BIANCHI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DIANA W. BIANCHI', 18)}}的其他基金
Feto-maternal DNA/RNA Trafficking: Biology and Application
胎儿-母体 DNA/RNA 贩运:生物学和应用
- 批准号:
8054127 - 财政年份:2010
- 资助金额:
$ 21.02万 - 项目类别:
15th International Society for Prenatal Diagnosis Meeting
第十五届国际产前诊断学会会议
- 批准号:
8007176 - 财政年份:2010
- 资助金额:
$ 21.02万 - 项目类别:
Feto-maternal DNA/RNA Trafficking: Biology and Application
胎儿-母体 DNA/RNA 贩运:生物学和应用
- 批准号:
7863894 - 财政年份:2009
- 资助金额:
$ 21.02万 - 项目类别:
14th International Society for Prenatal Diagnosis Meeting
第14届国际产前诊断学会会议
- 批准号:
7485459 - 财政年份:2008
- 资助金额:
$ 21.02万 - 项目类别:
The Role of Fetal Cell Microchimerism in Maternal Repair
胎儿细胞微嵌合在母体修复中的作用
- 批准号:
7055298 - 财政年份:2005
- 资助金额:
$ 21.02万 - 项目类别:
相似海外基金
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 21.02万 - 项目类别:
Fellowship
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
RareKids-CAN:儿科罕见病临床试验和治疗网络
- 批准号:
495575 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Operating Grants
Unbiased estimation in hierarchical models for Clinical trials
临床试验分层模型中的无偏估计
- 批准号:
2884930 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Studentship
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
CCTN-CONTRACEPTIVE DEVELOPMENT PROGRAM-NICHD CONTRACEPTIVE CLINICAL TRIALS NETWORK-FEMALE SITES-CORE FUNCTION ACTIVITIES
CCTN-避孕发展计划-NICHD避孕临床试验网络-女性站点-核心功能活动
- 批准号:
10895949 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
CONTRACEPTIVE CLINICAL TRIALS NETWORK, CCTN - FEMALE SITES 'CORE FUNCTION ACTIVITIES
避孕临床试验网络,CCTN - 女性站点的核心功能活动
- 批准号:
10891325 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
ISimcha Technology Platform for Recruiting a Diverse Population of Older Adults into Clinical Trials
ISimcha 技术平台,用于招募不同的老年人群进行临床试验
- 批准号:
10761602 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE)
在津巴布韦实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (ZIM-CASCADE)
- 批准号:
10758129 - 财政年份:2023
- 资助金额:
$ 21.02万 - 项目类别:














{{item.name}}会员




